Chitosan-capped, mesoporous silica NPs modified with aptamer for concomitant administration of daunorubicin and cytarabine in leukemia patients (Heydari et al., 2023)
Its distinctive inactive-to-active conversion within the tumor microenvironment augments metabolic targeting and selectivity, which underscores its potential as a groundbreaking therapeutic strategy [186, 187]
You have a pre-existing medical condition, such as liver or kidney disease
In addition, semaglutide had the greatest risk of nausea, diarrhea, vomiting, constipation, and pancreatitis, while liraglutide had the greatest risk when it came to upper abdominal pain
A generic formulation that achieves the same clinical performance as the branded product through a different polymer matrix, a different excipient system, or a different device mechanism does not infringe the branded delivery patents
But when you stop taking that medication, you may experience both heightened cravings and blood sugar levels